Radiopharmaceuticals and Tracers

This channel includes news and new technology innovations for nuclear and molecular imaging agents, radiotracers and radiopharmaceuticals used in PET or SPECT imaging. This includes advances in myocardiac perfusion agents.

News | January 30, 2012
January 30, 2012 — Positron Corp., a molecular imaging healthcare company specializing in the field of nuclear...
News | January 20, 2012
January 20, 2012 – Nuclear cardiology imaging company Positron Corp. this week acquired Manhattan Isotope Technology...
News | January 13, 2012
January 13, 2012 – The U.S. Food and Drug Administration (FDA) is updating healthcare professionals and the public...
News | January 06, 2012
January 6, 2012 – Bracco Diagnostics said it plans to close out the recall process for its CardioGen-82 cardiac...

Lantheus is developing flurpiridaz (an 18-F labeled PET agent) to help detect smaller occlusions. It has a half-life of two hours and is expected to undergo final FDA review in 2014.

Feature | November 22, 2011 | Dave Fornell
There are currently three major trends in cardiac nuclear perfusion imaging technology: advances in detector hardware,...
News | October 31, 2011
October 31, 2011 –Lantheus Medical announced it has been awarded a three-year supplier contract with Premier Purchasing...
News | August 24, 2011
August 24, 2011 -- Radiopharmaceuticals are pharmaceutical agents used to diagnose certain medical problems, such as...
Technology | July 26, 2011 | Dave Fornell
July 26, 2011 – The U.S. Food and Drug Administration (FDA) is alerting healthcare professionals to stop using...
Videos | Nuclear Imaging | June 27, 2011
Society of Nuclear Medicine (SNM) President George Segall, M.D., chief of the nuclear medicine service at the VA Palo...
Technology | June 13, 2011
June 13, 2011 - Expanding upon its radiopharmacy platform, GE Healthcare is introducing new tracers to the FASTlab...
News | June 20, 2011
June 10, 2011 — At the Society of Nuclear Medicine’s 58th Annual Meeting in San Antonio, June 4-8, Cardinal Health...
News | June 20, 2011
June 8, 2011 – Research introduced at the Society of Nuclear Medicine's 58th annual meeting this week may lead to much-...
Technology | May 20, 2011
May 20, 2011 – Medrad Inc., a business of Bayer HealthCare, has announced the launch of the next generation Intego PET...
News | May 18, 2011
May 18, 2011 – Lantheus Medical Imaging Inc. announced data from a phase 2 clinical trial that demonstrated positron...
Feature | March 15, 2011 | Jim Katzaroff
Much of nuclear imaging depends on a steady supply of an isotope called molybdenum-99 (Mo-99). A byproduct of nuclear...